• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA - A2亚型在肽结合和呈递方面功能各异。

HLA-A2 subtypes are functionally distinct in peptide binding and presentation.

作者信息

Barouch D, Friede T, Stevanović S, Tussey L, Smith K, Rowland-Jones S, Braud V, McMichael A, Rammensee H G

机构信息

Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

出版信息

J Exp Med. 1995 Dec 1;182(6):1847-56. doi: 10.1084/jem.182.6.1847.

DOI:10.1084/jem.182.6.1847
PMID:7500030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2192253/
Abstract

Nearly half of HLA-A2-positive individuals in African populations have a subtype of HLA-A2 other than the A0201 allele. We have isolated the common African HLA-A2 subtype genes from Epstein-Barr virus-transformed B cell lines and have established stable class I reduced transfectants expressing these alleles. We have studied the peptide binding and presentation properties of A0201, A0202, A0205, A0214, and A6901 by a combination of approaches: assaying direct binding of labeled synthetic peptides, studying the ability of antigen-specific cytotoxic T lymphocytes to recognize peptide-pulsed cells, and sequencing peptide pools and individual ligands eluted from cells. We find that A0201-restricted peptides can also bind to A0202 but do not bind strongly to the other alleles in this study. We show that some cytotoxic T lymphocytes can recognize all subtypes capable of binding an antigenic peptide, whereas others are subtype specific. Sequencing of eluted peptides reveals that A0202 has a similar peptide motif to A0201, but that A0205, A0214, and A*6901 have different motifs. These data strongly support a model in which residue 9 (Phe or Tyr) of the A2/A68/A69 molecules is a critical factor in determining the specificity of the B pocket of the major histocompatibility complex and the position 2 anchor residue of associated peptides. We conclude that a single-amino acid difference in the major histocompatibility complex can be sufficient to cause a dramatic change in the nature of bound peptides, implying that individuals with closely related HLA subtypes may present very different repertoires of antigenic peptides to T cells in an immune response. It is likely to be a general phenomenon that very similar class I subtypes will behave as functionally distinct HLA allotypes.

摘要

非洲人群中近一半的HLA - A2阳性个体拥有除A0201等位基因之外的HLA - A2亚型。我们从爱泼斯坦 - 巴尔病毒转化的B细胞系中分离出常见的非洲HLA - A2亚型基因,并建立了表达这些等位基因的稳定的I类减少转染细胞系。我们通过多种方法研究了A0201、A0202、A0205、A0214和A6901的肽结合和呈递特性:检测标记合成肽的直接结合、研究抗原特异性细胞毒性T淋巴细胞识别肽脉冲细胞的能力以及对从细胞中洗脱的肽库和单个配体进行测序。我们发现A0201限制的肽也能与A0202结合,但在本研究中与其他等位基因结合不强。我们表明,一些细胞毒性T淋巴细胞可以识别所有能够结合抗原肽的亚型,而其他细胞毒性T淋巴细胞则具有亚型特异性。洗脱肽的测序显示A0202与A0201具有相似的肽基序,但A0205、A0214和A*6901具有不同的基序。这些数据有力地支持了一个模型,其中A2/A68/A69分子的第9位残基(苯丙氨酸或酪氨酸)是决定主要组织相容性复合体B口袋特异性和相关肽的第2位锚定残基位置的关键因素。我们得出结论,主要组织相容性复合体中的单个氨基酸差异可能足以导致结合肽性质的显著变化,这意味着具有密切相关HLA亚型的个体在免疫反应中可能向T细胞呈递非常不同的抗原肽库。很可能是一种普遍现象,即非常相似的I类亚型将表现为功能上不同的HLA同种异型。

相似文献

1
HLA-A2 subtypes are functionally distinct in peptide binding and presentation.HLA - A2亚型在肽结合和呈递方面功能各异。
J Exp Med. 1995 Dec 1;182(6):1847-56. doi: 10.1084/jem.182.6.1847.
2
Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy.HLA - A2亚型对源自黑色素瘤抗原MART - 1和糖蛋白 - 100的肽段的结合与呈递。对基于肽段的免疫疗法的意义。
J Immunol. 1996 May 15;156(10):3882-91.
3
The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove.肽与HLA - A2结合的动力学以及肽 - A2复合物的构象可由肽结合槽底部的氨基酸侧链来确定。
Int Immunol. 1990;2(3):193-200. doi: 10.1093/intimm/2.3.193.
4
Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.HLA - A2第97位氨基酸的替换将MART - 1/Melan - A肽AAGIGILTV特异性细胞毒性T淋巴细胞中的细胞溶解与细胞因子释放区分开来。
Eur J Immunol. 1996 Nov;26(11):2613-23. doi: 10.1002/eji.1830261112.
5
Anchor residue motifs of HLA class-I-binding peptides analyzed by the direct binding of synthetic peptides to HLA class I alpha chains.通过合成肽与HLA I类α链的直接结合分析HLA I类结合肽的锚定残基基序。
Hum Immunol. 1993 Nov;38(3):187-92. doi: 10.1016/0198-8859(93)90539-d.
6
In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen.体外产生对源自前列腺特异性抗原的肽具有特异性的人细胞毒性T淋巴细胞。
J Natl Cancer Inst. 1997 Feb 19;89(4):293-300. doi: 10.1093/jnci/89.4.293.
7
HLA-B37 and HLA-A2.1 molecules bind largely nonoverlapping sets of peptides.HLA - B37分子和HLA - A2.1分子结合的肽段集合在很大程度上不重叠。
Proc Natl Acad Sci U S A. 1990 May;87(9):3420-4. doi: 10.1073/pnas.87.9.3420.
8
Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.对HLA - A2和HLA - E具有双重结合特异性的肽由抗氧化酶过氧化物酶5的可变剪接异构体编码。
Int Immunol. 2009 Mar;21(3):257-68. doi: 10.1093/intimm/dxn141. Epub 2009 Jan 30.
9
Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling.通过分子建模选择与HLA - A2.1分子结合的肽段。
Mol Immunol. 1996 Feb;33(2):221-30. doi: 10.1016/0161-5890(95)00065-8.
10
The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping.HLA I类分子的肽结合特异性在很大程度上具有等位基因特异性且互不重叠。
Mol Immunol. 1992 Sep;29(9):1131-40. doi: 10.1016/0161-5890(92)90046-z.

引用本文的文献

1
Evolution by innovation as a driving force to improve TCR-T therapies.通过创新实现进化作为改善TCR-T疗法的驱动力。
Front Oncol. 2023 Sep 21;13:1216829. doi: 10.3389/fonc.2023.1216829. eCollection 2023.
2
Association Between HTLV-1 Genotypes and Risk of HAM/TSP.人类嗜T淋巴细胞病毒1型(HTLV-1)基因型与热带痉挛性截瘫/人类T淋巴细胞病毒1型相关脊髓病(HAM/TSP)风险之间的关联
Front Microbiol. 2019 May 15;10:1101. doi: 10.3389/fmicb.2019.01101. eCollection 2019.
3
TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants.TCR 样抗体针对表达不同 HLA-A*02 微变异体的 Epstein-Barr 病毒转化的 B 淋巴母细胞系介导补体和抗体依赖性细胞细胞毒性作用。
Sci Rep. 2017 Aug 30;7(1):9923. doi: 10.1038/s41598-017-10265-6.
4
Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy.犬MHC I类分子DLA-88*50101肽结合基序的表征作为犬T细胞免疫治疗的前提条件。
PLoS One. 2016 Nov 28;11(11):e0167017. doi: 10.1371/journal.pone.0167017. eCollection 2016.
5
Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival.辅助疫苗免疫治疗切除的、临床淋巴结阴性黑色素瘤:长期结果和 HLA Ⅰ类抗原表达对总生存的影响。
Cancer Immunol Res. 2014 Oct;2(10):981-7. doi: 10.1158/2326-6066.CIR-14-0052. Epub 2014 Jul 3.
6
The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.免疫显性甲型流感病毒M158 - 66细胞毒性T淋巴细胞表位在人类中表现出I类主要组织相容性复合体的简并性限制。
J Virol. 2014 Sep;88(18):10613-23. doi: 10.1128/JVI.00855-14. Epub 2014 Jul 2.
7
Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing.通过组特异性扩增和单等位基因测序对 HLA-A*02 等位基因进行全面筛查和准确分型。
Cell Mol Immunol. 2013 Nov;10(6):490-6. doi: 10.1038/cmi.2013.33. Epub 2013 Aug 19.
8
Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes.HLA-A*6802 和 HLA-A*6801 被分为 A2 和 A3 超型的结构基础。
Mol Immunol. 2013 Oct;55(3-4):381-92. doi: 10.1016/j.molimm.2013.03.015. Epub 2013 Apr 6.
9
Structural and functional distinctiveness of HLA-A2 allelic variants.HLA-A2 等位基因变异体的结构和功能特征。
Immunol Res. 2012 Sep;53(1-3):182-90. doi: 10.1007/s12026-012-8295-5.
10
Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands.从大规模 MHC I 类配体分析中获得的 MHC I 类抗原加工的见解。
Cell Mol Life Sci. 2011 May;68(9):1521-32. doi: 10.1007/s00018-011-0659-9. Epub 2011 Mar 9.

本文引用的文献

1
Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.三种人类组织相容性抗原中P2特异性口袋的比较:HLA-A*6801、HLA-A*0201和HLA-B*2705
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8053-7. doi: 10.1073/pnas.90.17.8053.
2
Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
J Immunol. 1994 Feb 1;152(3):1213-21.
3
Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.HLA-B*2702和B*2705肽基序中占主导地位的芳香族/脂肪族C末端锚定序列。
Immunogenetics. 1994;39(1):74-7. doi: 10.1007/BF00171803.
4
Restoration of CTL recognition of a mutant FMP peptide by a compensatory change in HLA-A2.
Immunogenetics. 1994;40(1):66-9. doi: 10.1007/BF00163966.
5
Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy.针对密切相关的B*2705和B*2703亚型的同种异体反应性T细胞应答的克隆分析。对HLA - B27与脊柱关节病关联的意义。
J Immunol. 1994 Jun 1;152(11):5557-71.
6
Both major and minor peptide-binding pockets in HLA-A2 influence the presentation of influenza virus matrix peptide to cytotoxic T lymphocytes.HLA - A2中的主要和次要肽结合口袋均会影响流感病毒基质肽向细胞毒性T淋巴细胞的呈递。
Mol Immunol. 1994 Apr;31(6):459-70. doi: 10.1016/0161-5890(94)90065-5.
7
Anchor residue motifs of HLA class-I-binding peptides analyzed by the direct binding of synthetic peptides to HLA class I alpha chains.通过合成肽与HLA I类α链的直接结合分析HLA I类结合肽的锚定残基基序。
Hum Immunol. 1993 Nov;38(3):187-92. doi: 10.1016/0198-8859(93)90539-d.
8
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules.二级锚定残基在肽与HLA - A2.1分子结合中的重要作用。
Cell. 1993 Sep 10;74(5):929-37. doi: 10.1016/0092-8674(93)90472-3.
9
HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products.
Hum Immunol. 1994 Mar;39(3):155-62. doi: 10.1016/0198-8859(94)90255-0.
10
Nomenclature for factors of the HLA system, 1994.1994年人类白细胞抗原(HLA)系统因子命名法。
Tissue Antigens. 1994 Jul;44(1):1-18. doi: 10.1111/j.1399-0039.1994.tb02351.x.